Lates News
Amicus Therapeutics (FOLD.US): The revenue in Q1 of 2025 reached 1.252 billion US dollars, compared to the previous value of 1.104 billion US dollars and an expected value of 1.363 billion US dollars; earnings per share were 0.03 US dollars, compared to -0.02 US dollars in the previous period, with an expected value of 0.08 US dollars.
Latest